Atriva Therapeutics GmbH logo

Atriva Therapeutics GmbH

ATRIVA aims to develop antiviral medications for different indications and viral infections. The most advanced lead indication is Influenza in patients at risk for developing severe complications due to comorbidities.

KEY DETAILS

Websitehttps://www.atriva-therapeutics.com
Founded
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Christophstr. 32, 72072
Tubingen
Germany
Email
Contact Number
+49 7071 8597673